MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Bausch Health Cos Inc

Open

BrancheGesundheitswesen

5.34 0.95

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.28

Max

5.47

Schlüsselkennzahlen

By Trading Economics

Einkommen

190M

98M

Verkäufe

49M

2.6B

EPS

1.16

Gewinnspanne

3.83

Angestellte

20,700

EBITDA

206M

853M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+50.55% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

30. Apr. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-595M

1.7B

Vorheriger Eröffnungskurs

4.39

Vorheriger Schlusskurs

5.34

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Bausch Health Cos Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Apr. 2025, 13:12 UTC

Akquisitionen, Fusionen, Übernahmen

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

17. Okt. 2024, 23:57 UTC

Heiße Aktien

Stocks to Watch: Netflix, MGP Ingredients, Bausch Health

Peer-Vergleich

Kursveränderung

Bausch Health Cos Inc Prognose

Kursziel

By TipRanks

50.55% Vorteil

12-Monats-Prognose

Durchschnitt 8.25 USD  50.55%

Hoch 12 USD

Tief 5 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Bausch Health Cos Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

0

Buy

5

Halten

1

Sell

Technischer Score

By Trading Central

4.52 / N/AUnterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.